|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
3
|
Resverlogix Corp.
|
May 03, 2019 01:55PM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
2
|
Resverlogix Corp.
|
May 03, 2019 02:15PM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
3
|
Resverlogix Corp.
|
May 03, 2019 04:48PM
|
|
Re: Updated List of BET inhibitors
|
5
|
Zenith Epigenetics
|
Apr 10, 2019 03:27PM
|
|
Re: Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
Feb 02, 2018 12:37PM
|
|
Re: Update
|
2
|
Resverlogix Corp.
|
Feb 14, 2018 04:50AM
|
|
Re: Update
|
4
|
Resverlogix Corp.
|
Jun 12, 2019 09:33AM
|
|
Re: Upcoming Dimentia news in early Dec
|
4
|
Resverlogix Corp.
|
Nov 05, 2019 03:21AM
|
|
Re: UpComing Catalyst(s)
|
5
|
Resverlogix Corp.
|
Nov 11, 2020 11:05PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 11:22PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 12:50AM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 07:41PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 08:40PM
|
|
Re: Two big thank you’s
|
1
|
Zenith Epigenetics
|
Nov 25, 2022 02:23PM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
5
|
Resverlogix Corp.
|
Jul 09, 2021 12:26PM
|
|
Re: Twitter and Facebook....
|
4
|
Resverlogix Corp.
|
Dec 01, 2017 02:54AM
|
|
Re: Tweet from Prof Kausik Ray
|
7
|
Resverlogix Corp.
|
Jun 02, 2020 11:10PM
|
|
Re: Tweet from Prof Kausik Ray
|
6
|
Resverlogix Corp.
|
Jun 02, 2020 11:15PM
|
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
May 31, 2020 11:49PM
|
|
Re: Tundup's message
|
9
|
Resverlogix Corp.
|
Apr 13, 2019 08:34PM
|
